Skip to main content

Table 4 Results of multivariate analysis of significant factors associated with progression-free survival (PFS)

From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

Variable (N = 137)

PFS

HR

95%CI

Multivariate (P value)

TC

1.841

1.187–2.857

0.006

  < 4.77

   

  ≥ 4.77

   

LDL

2.133

1.336–3.406

0.002

  < 2.965

   

  ≥ 2.965

   
  1. The unit of measurement for lipids is mmol/L
  2. HR hazard ratio, CI confidence interval, TC total cholesterol, LDL low density lipoprotein